Catalyst Wire Dossier Catalyst Wire Dossier

Zorifertinib

Zorifertinib · Alpha Biopharma (Jiangsu) Co., Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Zorifertinib, covering 2026-01-23 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKI [Phase 2]

See pricing